Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

NCT ID: NCT07415954
Registry status: Recruiting
Study type: Not specified in the registry data
Phase: Phase 2
Sponsor: Novo Nordisk A/S

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 270 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages: Not specified in the registry data
Sex: Not specified in the registry data
Healthy volunteers accepted: No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion criteria * Male or female (sex at birth). * Age 18-75 years (both inclusive) at the time of signing the informed consent. * Glycated haemoglobin (HbA1c) of 7.0-10.0 percent (%) (53-86 millimoles per mole \[mmol/mol\]) (both inclusive) as assessed by central laboratory at screening. * Willingness to obtain a high weight loss (greater than \[\>\] 25% of weight at baseline). Exclusion criteria * Treatment with any medication for the indication of diabetes or obesity other than stated in the inclusion criteria within 90 days before screening. However, short term insulin treatment for a maximum of 14 consecutive days and prior insulin treatment for gestational diabetes are allowed. * Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for non-dilated examination. * Known hypoglycaemic unawareness as indicated by the investigator according to Clarke's Questionnaire.

Study locations

63 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: Croatia, Hungary, Japan, Poland, Portugal, Slovakia, South Korea, Spain, Thailand, United States

Csongrád-Csanád, Hungary: 1
Hajdú-Bihar, Hungary: 1
Podlaskie Voivodeship, Poland: 1
Gyeonggi-do, South Korea: 1
Gyeongsangnam-do, South Korea: 1
Barcelona, Spain: 1
California, United States: 6
Florida, United States: 5
Idaho, United States: 1
Illinois, United States: 1
Massachusetts, United States: 1
Missouri, United States: 1
North Carolina, United States: 2
Ohio, United States: 1
Tennessee, United States: 1
Texas, United States: 3
West Virginia, United States: 1

Sample of listed locations

Opca bolnica Karlovac — Karlovac, 47000, Croatia — Site recruitment status not specified in the registry data
Poliklinika SLAVONIJA OSIJEK — Osijek, 31000, Croatia — Site recruitment status not specified in the registry data
Opca bolnica Varazdin_Endocrinology — Varaždin, 42 000, Croatia — Site recruitment status not specified in the registry data
Poliklinika Solmed — Zagreb, 10000, Croatia — Site recruitment status not specified in the registry data
Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ — Szeged, Csongrád-Csanád, 6725, Hungary — Site recruitment status not specified in the registry data
Debreceni Egyetem — Debrecen, Hajdú-Bihar, 4032, Hungary — Site recruitment status not specified in the registry data
Debreceni Egyetem — Debrecen, 4031, Hungary — Site recruitment status not specified in the registry data
Akaicho Clinic_Internal medicine — Chiba-shi, Chiba, 260-0804, Japan — Site recruitment status not specified in the registry data
Naka Kinen Clinic_Internal medicine — Ibaraki, 311-0113, Japan — Site recruitment status not specified in the registry data
Soka Sugiura Internal Medicine Clinic — Soka-shi, Saitama, 340-0015, Japan — Site recruitment status not specified in the registry data
ToCROM Clinic_Internal Medicine — Tokyo, 160-0008, Japan — Site recruitment status not specified in the registry data
Tokyo-Eki Center-building Clinic_Internal Medicine — Tokyo, 103-0027, Japan — Site recruitment status not specified in the registry data
"Zdrowie Osteo-Medic" s.c. Lidia i Artur Racewicz, Agnieszka i Jerzy Supronik — Bialystok, Podlaskie Voivodeship, 15-351, Poland — Site recruitment status not specified in the registry data
Terpa Sp. z o.o. Sp. k. — Lublin, 20-333, Poland — Site recruitment status not specified in the registry data
Formed 2 Sp. z o.o. — Oświęcim, 32-600, Poland — Site recruitment status not specified in the registry data
PANSTWOWY INSTYTUT MEDYCZNY MSWiA — Warsaw, 02-507, Poland — Site recruitment status not specified in the registry data
Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Szyszko — Zabrze, 41-800, Poland — Site recruitment status not specified in the registry data
Casa De Saúde De Santa Filomena S.A._Unidade de Ensaios Clínicos — Coimbra, 3000-150, Portugal — Site recruitment status not specified in the registry data
Cardiolima Centro Diagnostico Cardio-Pulmonar De Ponte De Lima Lda — Ponte de Lima, 4990-029, Portugal — Site recruitment status not specified in the registry data
Hospital Trofa Saude Senhor do Bonfim S.A_Unidade de Ensaios Clínicos — Vila do Conde, 4480-565, Portugal — Site recruitment status not specified in the registry data
Hospital da Luz Arrábida, S.A_Serviço de Endocrinologia — Vila Nova de Gaia, 4400-346, Portugal — Site recruitment status not specified in the registry data
DIADA, s.r.o. — Bardejov, 08501, Slovakia — Site recruitment status not specified in the registry data
Diacrin s. r. o. — Bratislava, 83101, Slovakia — Site recruitment status not specified in the registry data
Metabol KLINIK s.r.o. — Bratislava, 811 08, Slovakia — Site recruitment status not specified in the registry data
SIN AZUCAR s.r.o. — Malacky, 901 01, Slovakia — Site recruitment status not specified in the registry data

Study details

Start date: April 17, 2026
Primary completion date: September 3, 2027
First posted: February 17, 2026

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT07415954
Registry last updated: September 11, 2026
QualifiedStudies registry data refreshed: September 21, 2026

View NCT07415954 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Diabetes (Type II) studies | Clinical trial FAQ